Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump

cafead

Administrator
Staff member
  • cafead   Dec 10, 2024 at 10:02: PM
via Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug affordability were some policy focuses for the company in a second Trump administration.

article source